MIX is found in 4 entries

MIX as free ligands, exist in 4 entries. Examples include 2FUM, 2KGP, 4G0V

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
Formula C22 H28 N4 O6
Molecular Weight 444.48 g/mol
Type non-polymer
Isomeric SMILES OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12
InChI InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2

Chemical Details

Formal Charge 0
Atom Count 60
Chiral Atom Count 0
Chiral Atoms
Bond Count 62
Aromatic Bond Count 12

Drug Info: DrugBank

DrugBank ID DB01204   (Stereoisomeric match)
Name Mitoxantrone
  • approved
  • investigational
Description An anthracenedione-derived antineoplastic agent. [PubChem]
  • 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
  • Mitoxantrona
  • Mitoxantrone
  • Mitoxantronum
Salts Mitoxantrone hydrochloride
Brand Names
  • Mitoxantrone
  • Mitoxantrone Hydrochloride
  • Mitoxantrone Injection
  • Mitoxantrone Injection USP
  • Novantrone
Affected Organism Humans and other mammals
Indication For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis
Pharmacology Mitoxantrone has been shown in vitro to inhibit B cell, T cell, and macrophage proliferation and impair antigen presentation, as well as the secretion of interferon gamma, TNFa, and IL-2.
Mechanism of action Mitoxantrone, a DNA-reactive agent that intercalates into deoxyribonucleic acid (DNA) through hydrogen bonding, causes crosslinks and strand breaks. Mitoxantrone also interferes with ribonucleic acid (RNA) and is a potent inhibitor of topoisomerase II, an enzyme responsible for uncoiling and repairing damaged DNA. It has a cytocidal effect on both proliferating and nonproliferating cultured human cells, suggesting lack of cell cycle phase specificity.
Route of administration intravenous
  • Antineoplastic Agents
  • Analgesics
  • Antineoplastic Agents (Anthracycline, Systemic)
ATC-Code L01DB07
AHFS-Code 10:00.00
CAS number 65271-80-9

Drug Targets

Name Sequence Search Pharmacological Action Actions
DNA topoisomerase 2-alpha Search yes inhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682